Single centre, open-label, intra-individual, comparison, proof of concept study to determine the efficacy of an artemether topical formulation in subjects with seborrheic keratosis

Trial Profile

Single centre, open-label, intra-individual, comparison, proof of concept study to determine the efficacy of an artemether topical formulation in subjects with seborrheic keratosis

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Artemether (Primary)
  • Indications Seborrhoeic keratosis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors EpiPharm AG
  • Most Recent Events

    • 24 Jul 2015 Status changed from active, no longer recruiting to completed as per ISRCTN: Current Controlled Trials record.
    • 03 Mar 2015 New trial record
    • 24 Feb 2015 Status changed from recruiting to active, no longer recruiting as per ISRCTN record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top